Comparison of the effect of tropicamide 0.5% and tropicamide 1% on intraocular pressure, pupil size, keratometry and anterior chamber parameters in patients with type 1 and type 2 diabetes mellitus

This study is a double-masked randomized clinical trial (registration ID: ClinicalTrials.gov, NCT04932213) that compared the effect of tropicamide 0.5% and tropicamide 1% on IOP, pupil Size, keratometry, white to white, central corneal thickness, and anterior chamber parameters including ACD, ACV, and ACA in patients with type 1 and type 2 diabetes mellitus.

本研究为一项双盲随机临床试验，注册编号为ClinicalTrials.gov平台的NCT04932213，旨在对比0.5%托吡卡胺与1%托吡卡胺对1型及2型糖尿病患者的眼内压（IOP）、瞳孔尺寸、角膜曲率、白对白距离、中央角膜厚度，以及前房深度（ACD）、前房容积（ACV）、前房角（ACA）等前房参数的影响。